Sagamihara, Japan

Toshihiro Shimbo

This inventor holds 1 USPTO granted patent. Top assignee: The Kitasato Institute. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshihiro Shimbo

Introduction

Toshihiro Shimbo is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of ischemia-reperfusion injury. His innovative approach aims to minimize side effects while effectively addressing this critical medical condition.

Latest Patents

One of Toshihiro Shimbo's key patents is a therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury. This invention focuses on a treatment method that involves the administration by inhalation of a mixed gas comprising 21%-98% oxygen, 0.1%-4% hydrogen, 40-80 ppm nitrogen monoxide, and a remainder of inert gas such as nitrogen or helium. This method is designed for patients undergoing reperfusion, starting from immediately before the onset of ischemia-reperfusion until shortly after reperfusion begins. This patent highlights his commitment to advancing medical treatments with reduced risks.

Career Highlights

Toshihiro Shimbo is associated with The Kitasato Institute, where he collaborates with other experts in the field. His work has been instrumental in developing innovative solutions that address complex medical challenges. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Toshihiro Shimbo has worked alongside notable colleagues such as Kenichi Kokubo and Hirosuke Kobayashi. These collaborations have fostered an environment of innovation and have contributed to the advancement of medical technologies.

Conclusion

Toshihiro Shimbo's contributions to the field of medical technology, particularly through his patent for treating ischemia-reperfusion injury, demonstrate his innovative spirit and commitment to improving patient outcomes. His work at The Kitasato Institute and collaborations with esteemed colleagues further highlight his impact in the medical research community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…